Firefly, NeuroSigma partner on pediatric ADHD treatment
Firefly (NASDAQ: AIFF) and NeuroSigma said they are partnering to expand access to a first FDA-cleared, non-drug treatment for pediatric ADHD.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.